Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Endologix Inc (ELGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 416,509
  • Shares Outstanding, K 82,970
  • Annual Sales, $ 192,930 K
  • Annual Income, $ -154,680 K
  • 36-Month Beta 0.65
  • Price/Sales 2.20
  • Price/Cash Flow 0.00
  • Price/Book 4.46

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.68 +7.26%
on 06/23/17
5.45 -7.89%
on 06/27/17
+0.34 (+7.26%)
since 06/21/17
3-Month
4.20 +19.52%
on 05/18/17
7.66 -34.46%
on 05/01/17
-1.91 (-27.56%)
since 04/21/17
52-Week
4.20 +19.52%
on 05/18/17
14.41 -65.16%
on 07/28/16
-8.76 (-63.57%)
since 07/21/16

Most Recent Stories

More News
Robbins Arroyo LLP Is Investigating the Officers and Directors of Endologix, Inc. (ELGX) on Behalf of Shareholders

Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Endologix, Inc. (NasdaqGS: ELGX) breached their fiduciary duties to shareholders...

ELGX : 5.02 (-1.76%)
Merit Medical is Among the Companies in the Health Care Supplies Industry with the Best Relative Performance (MMSI, ALGN, ELGX, QDEL, COO)

Below are the top five companies in the Health Care Supplies industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

MMSI : 38.25 (-2.92%)
COO : 248.41 (-2.20%)
ELGX : 5.02 (-1.76%)
ALGN : 158.87 (-0.81%)
QDEL : 37.71 (-0.05%)
Endologix, Inc. to Present at the Canaccord Genuity 37th Annual Growth Conference

Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that John McDermott, Chief Executive Officer, and Vaseem Mahboob, Chief...

ELGX : 5.02 (-1.76%)
Lifshitz & Miller LLP Announces Investigation of Aaron's, Inc., Axiom Holdings, Inc., Booz Allen Hamilton Holding Corporation, CenturyLink, Inc., Endologix, Inc., Sky Solar Holdings, Ltd. and Rightside Group, Ltd.

Aaron's, Inc. (AAN)

SKYS : 1.42 (+2.90%)
ELGX : 5.02 (-1.76%)
AIOME : 0.6100 (-4.84%)
BAH : 33.66 (+0.36%)
CTL : 23.37 (+0.65%)
AAN : 39.78 (+0.63%)
NAME : 10.60 (+0.09%)
Medical Supplies Stocks on Investors' Radar -- Endologix, Microbot Medical, ConforMIS, and Insulet

If you want a stock review on ELGX, MBOT, CFMS, or PODD then come over to http://dailystocktracker.com/register/ and sign up for your free customized reports today. On Tuesday, June 20, 2017, US markets...

CFMS : 4.66 (-0.21%)
ELGX : 5.02 (-1.76%)
PODD : 51.43 (+2.04%)
MBOT : 1.20 (-9.77%)
ENDOLOGIX ALERT: J&W Investigates Endologix, Inc.; Long Term Investors Encouraged to Contact the Firm

Johnson & Weaver, LLP is investigating potential violations of federal and state securities laws by Endologix, Inc. (NASDAQ: ELGX) and certain of its officers.

ELGX : 5.02 (-1.76%)
Endologix Presents Positive Two-Year Clinical Data from the Nellix(R) EVAS FORWARD IDE Trial

Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced the presentation of two-year clinical data from the Company's Nellix(R)...

ELGX : 5.02 (-1.76%)
Endologix Reports Positive Clinical Data from the Ovation LUCY Study

Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced 30-day results from the LUCY (Evaluation of FemaLes who are Underrepresented...

ELGX : 5.02 (-1.76%)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Endologix, Inc. - ELGX

Levi & Korsinsky, LLP announces it has commenced an investigation of Endologix, Inc. (NASDAQ:ELGX) concerning possible breaches of fiduciary duty. To obtain additional information, go to:...

ELGX : 5.02 (-1.76%)
Endologix Provides an Update on the Nellix(R) Endovascular Aneurysm Sealing System U.S. Regulatory Status

Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that the Company met with the Food and Drug Administration (FDA) regarding...

ELGX : 5.02 (-1.76%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Falling.

See More

Business Summary

Endologix, Inc. develops, manufactures and markets products for the treatment of coronary and vascular diseases. A leader in the emerging field of vascular brachytherapy, Endologix, has developed a unique method for the delivery of radiation to prevent restenosis following the interventional treatment...

See More

Support & Resistance

2nd Resistance Point 5.23
1st Resistance Point 5.12
Last Price 5.02
1st Support Level 4.96
2nd Support Level 4.91

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.